"Testing early and comprehensively curbs death. We need to test the right populations at the right scale." Catharina Boehme G20 Health & Development Partnership Women Political Leaders The Global Fund #TestToExit #COVID19 #GlobalGoalUnite

Check out OA on Air Healthcare, Joe Alviani chats w/Dr. Andrew Levin, Chief Executive/Chief Scientific Officer of #Framingham based Kephera Diagnostics, re: company's efforts to develop antibody test/testing kit for COVID19. soundcloud.com/user-409008964… O'Neill & Associates City of Framingham

We’re pleased to have interns Anton and Gabi at Kephera, through Massachusetts Life Sciences Center' Internship Challenge to feed our talent pipeline and help us quickly develop our antibody test for #COVID19.

“At Kephera, we put interns in the lab to help them learn the ropes and gain the knowledge of what’s involved in the business of test development." Interns playing a vital role during pandemic at Kephera Diagnostics. 🔗 ow.ly/xt8o50AwSXO

Kephera Diagnostics has been awarded a 2-year, Phase II Small Business Innovation Research (SBIR) grant by the National Institute of Allergy and Infectious Diseases (NIAID), an agency of the National Institutes of Health, to complete and launch a new t ... bit.ly/2CGz8CC

Kephera Diagnostics awarded Phase II grant from the National Institute of Allergy and Infectious Diseases (NAID) for Zika virus test | FirstWord MedTech firstwordmedtech.com/node/1034952 via FirstWord Pharma

Happy #NationalInternDay! Investing in the next generation of life science professionals is at the core of how we fulfill our mission at the MLSC. Since its inception in 2009, the Internship Challenge has produced more than 4,300 internships at nearly 800 companies throughout MA.

NIH Invests $248.7 Million to Ramp up COVID-19 Testing genengnews.com/news/nih-inves… via Genetic Engineering & Biotechnology News

Kephera Diagnostics is excited to announce its new CLIA laboratory has launched testing for COVID-19 antibodies. Contact us at [email protected] for details on how to submit blood samples for testing. bit.ly/33xItrk

Kephera Diagnostics - based in #Framingham announced that it has been approved as a CLIA certified laboratory by the Massachusetts Dept of Public Health and the U.S. Centers for Medicare and Medicaid, and is now offering COVID-19 antibody testing in Massachusetts and 44 other states.

Kephera is developing innovative point-of-care diagnostics to make #ChagasDisease visible now. #WorldChagasDisease #NoMasChagas #BeatNTDs #DiagnosticsMatter kephera.com

We are excited to announce our new quantitative antibody test for COVID-19 that measures your immune response after COVID-19 vaccination or infection. Learn how to get the test here: kephera.com/covid-19-testi…

Excited to announce a new contract from NIAID to develop a new test for Chagas disease. This contract will support the development and preliminary evaluation of a test that can discriminate active from successfully treated Chagas disease.

Kephera Diagnostics CLIA-certified lab will launch two assays testing for Chagas disease in May 2023: an FDA-approved ELISA and a new, multiplex test – both detect antibodies to the parasitic agent that causes the disease. #WorldChagasDay #chagasdisease #diagnostics

360dx.com/point-care-tes…

Thank you to Babson College for facilitating this opportunity and the MBA student team for their excellent project work! linkedin.com/posts/kephera-…

We’re proud to announce the launch of EndomTest™, the first commercially available blood test for endometriosis in the U.S.​ Order online at kephera.com/order-test/end…

Endometriosis, which causes severe pain and can make it difficult to get pregnant, can go undiagnosed in women for years. on.nbcboston.com/CgB2AtO

What if endometriosis could be detected by a blood test? EndomTest™ is now available in the US, the first non-invasive endometriosis test for the 6.5M women living with endometriosis. Your pain isn't normal. #Endometriosis #OverlookedButNotRare #KepheraDX